{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:35:11Z","timestamp":1787236511981,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clgc.2025.102415","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T07:21:20Z","timestamp":1755242480000},"page":"102415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-6767","authenticated-orcid":false,"given":"F.","family":"Mastroleo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"Vincini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Matrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-0940","authenticated-orcid":false,"given":"G.","family":"Timon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Augugliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Burgio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Francolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hasterok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4375-0827","authenticated-orcid":false,"given":"M.","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-1757","authenticated-orcid":false,"given":"N.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Spatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-559X","authenticated-orcid":false,"given":"M.","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clgc.2025.102415_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Ca J Clin"},{"issue":"6","key":"10.1016\/j.clgc.2025.102415_bib0002","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/bju.14062","article-title":"Laparoscopic and robot-assisted vs open radical prostatectomy for the treatment of localized prostate cancer: a Cochrane systematic review","volume":"121","author":"Ilic","year":"2018","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0003","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/s1677-5538.ibju.2016.0656","article-title":"Biochemical recurrence after radical prostatectomy: what does it mean?","volume":"44","author":"Tourinho-Barbosa","year":"2018","journal-title":"Int Braz J Urol"},{"issue":"9","key":"10.1016\/j.clgc.2025.102415_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.clgc.2025.102415_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2023.05.038","article-title":"European association of urology biochemical recurrence risk classification as a decision tool for salvage radiotherapy: a multicenter study","volume":"85","author":"Preisser","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102415_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.831429","article-title":"PSMA PET in imaging prostate cancer","volume":"12","author":"Tsechelidis","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.euo.2018.09.010","article-title":"A systematic review on the role of imaging in early recurrent prostate cancer","volume":"2","author":"De Visschere","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102415_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2020.11.043","article-title":"Is prostate-specific membrane antigen positron emission tomography\/computed tomography imaging cost-effective in prostate cancer: an analysis informed by the proPSMA trial","volume":"79","author":"De","year":"2021","journal-title":"Eur Urol"},{"issue":"27","key":"10.1016\/j.clgc.2025.102415_bib0009","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1200\/JCO.2017.73.9987","article-title":"Metastasis-free survival is a strong surrogate of overall survival in localized prostate cancer","volume":"35","author":"Xie","year":"2017","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12894-019-0448-6","article-title":"Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada","volume":"19","author":"Smith-Palmer","year":"2019","journal-title":"BMC Urol"},{"issue":"18","key":"10.1016\/j.clgc.2025.102415_bib0011","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1200\/JCO.2016.70.2811","article-title":"Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease","volume":"35","author":"Spratt","year":"2017","journal-title":"JCO"},{"issue":"4","key":"10.1016\/j.clgc.2025.102415_bib0012","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaoncol.2020.7671","article-title":"Validation of a 22-gene genomic classifier in patients with recurrent prostate cancer: an ancillary study of the NRG\/RTOG 9601 randomized clinical trial","volume":"7","author":"Feng","year":"2021","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.clgc.2025.102415_bib0013","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1007\/s00259-015-3302-4","article-title":"68Ga-PSMA-11 dynamic PET\/CT imaging in biochemical relapse of prostate cancer","volume":"43","author":"Sachpekidis","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clgc.2025.102415_bib0014","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. Accessed February 2, 2025. https:\/\/uroweb.org\/guidelines\/prostate-cancer"},{"key":"10.1016\/j.clgc.2025.102415_bib0015","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0, National Cancer Institute, 2017. Accessed February 2, 2025. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v5-5x7.pdf."},{"issue":"2","key":"10.1016\/j.clgc.2025.102415_bib0016","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-135-2-200107170-00012","article-title":"Adjustments for center in multicenter studies: an overview","volume":"135","author":"Localio","year":"2001","journal-title":"Ann Intern Med"},{"issue":"446","key":"10.1016\/j.clgc.2025.102415_bib0017","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"15","key":"10.1016\/j.clgc.2025.102415_bib0018","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"25","author":"Stephenson","year":"2007","journal-title":"JCO"},{"issue":"6","key":"10.1016\/j.clgc.2025.102415_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.02.024","article-title":"Ten-year disease progression and mortality rates in men who experience biochemical recurrence versus persistence after radical prostatectomy and undergo salvage radiation therapy: A post-hoc analysis of RTOG 9601 trial data","volume":"38","author":"Sood","year":"2020","journal-title":"Urol Oncol: Sem Orig Investig"},{"issue":"10","key":"10.1016\/j.clgc.2025.102415_bib0020","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/s10147-019-01463-5","article-title":"Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer","volume":"24","author":"Pak","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102415_bib0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.prro.2011.02.003","article-title":"PSA doubling time predicts for the development of distant metastases for patients who fail 3DCRT Or IMRT using the phoenix definition","volume":"1","author":"Klayton","year":"2011","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102415_bib0022","first-page":"470","article-title":"PSA doubling time and absolute PSA predict metastasis-free survival in men with biochemically recurrent prostate cancer after radical prostatectomy","volume":"17","author":"Markowski","year":"2019","journal-title":"Clin Genitour Ca"},{"issue":"5","key":"10.1016\/j.clgc.2025.102415_bib0023","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2016.08.043","article-title":"Salvage radiation therapy dose response for biochemical failure of prostate cancer after prostatectomy: a multi-institutional observational study","volume":"96","author":"Pisansky","year":"2016","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"issue":"30","key":"10.1016\/j.clgc.2025.102415_bib0024","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1200\/JCO.2016.67.9647","article-title":"Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy","volume":"34","author":"Tendulkar","year":"2016","journal-title":"JCO"},{"issue":"3","key":"10.1016\/j.clgc.2025.102415_bib0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/pcan.2016.18","article-title":"Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up","volume":"19","author":"Spratt","year":"2016","journal-title":"Prost Ca Prostat Dis"},{"issue":"3","key":"10.1016\/j.clgc.2025.102415_bib0026","doi-asserted-by":"crossref","DOI":"10.23736\/S0393-2249.18.03124-7","article-title":"Salvage radiation therapy after radical prostatectomy: survival analysis","volume":"71","author":"Galla","year":"2019","journal-title":"Minerva Urol Nefrol"},{"issue":"12","key":"10.1016\/j.clgc.2025.102415_bib0027","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.38550","article-title":"Performance of a prostate-specific membrane antigen positron emission tomography\/computed tomography\u2013derived risk-stratification tool for high-risk and very high-risk prostate cancer","volume":"4","author":"Xiang","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10338","key":"10.1016\/j.clgc.2025.102415_bib0028","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clgc.2025.102415_bib0029","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2024.07.026","article-title":"Randomised trial of no, short-term, or long-term androgen deprivation therapy with postoperative radiotherapy after radical prostatectomy: results from the three-way comparison of RADICALS-HD (NCT00541047)","volume":"86","author":"Parker","year":"2024","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102415_bib0030","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00259-023-06438-3","article-title":"The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy","volume":"51","author":"Adebahr","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0031","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s40644-024-00752-1","article-title":"Prognostic significance of a negative PSMA PET\/CT in biochemical recurrence of prostate cancer","volume":"24","author":"Harsini","year":"2024","journal-title":"Cancer Imaging"},{"issue":"10","key":"10.1016\/j.clgc.2025.102415_bib0032","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/j.1464-410X.2009.08623.x","article-title":"Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database","volume":"104","author":"Moreira","year":"2009","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clgc.2025.102415_bib0033","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2478\/raon-2021-0017","article-title":"Prognostic factors in postoperative radiotherapy for prostate cancer \u2013 tertiary center experience","volume":"55","author":"Miszczyk","year":"2021","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0034","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.euf.2023.07.004","article-title":"Multi-institutional development and external validation of a machine learning model for the prediction of distant metastasis in patients treated by salvage radiotherapy for biochemical failure after radical prostatectomy","volume":"10","author":"Sabbagh","year":"2024","journal-title":"Eur Urol Focus"},{"issue":"35","key":"10.1016\/j.clgc.2025.102415_bib0036","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1200\/JCO.2015.63.3529","article-title":"Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09\/10","volume":"33","author":"Ghadjar","year":"2015","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.clgc.2025.102415_bib0037","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rpor.2020.01.005","article-title":"Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer","volume":"25","author":"Mariucci","year":"2020","journal-title":"Rep Pract Oncol Radiother"},{"issue":"1","key":"10.1016\/j.clgc.2025.102415_bib0038","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41598-019-57056-9","article-title":"Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy","volume":"10","author":"Tomita","year":"2020","journal-title":"Sci Rep"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T21:09:51Z","timestamp":1770671391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1558767325001156"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102415","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102415"}}